Unknown PHASE4 INTERVENTIONAL 1-arm NCT01353105

Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion

Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo

Interventions Ex vivo lung transplantation

Updated 4 times since 2017 Last updated: May 11, 2011 Started: Aug 31, 2011 Primary completion: Aug 31, 2013 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Respiratory Tract Diseases and is currently ongoing. Fundação de Amparo à Pesquisa do Estado de São Paulo leads this study, which shows 4 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundação de Amparo à Pesquisa do Estado de São Paulo
InCor Heart Institute

Data source: InCor Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil